Development of New Antibody Based Theranostic Agents Targeting the Receptor for Advanced Glycation End-Product (Rage)
The Receptor for Advanced Glycation End products (RAGE) interacts with several classes of structurally unrelated ligands. The activation of RAGE by its ligands results in the cellular activation of several kinases and transcription factors including mitogen activated protein kinases (MAPKs) and nucl...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
North Dakota State University
2017
|
| Online Access: | https://hdl.handle.net/10365/26866 |